Liposome drug form with light-converting nanoparticles, a method of its preparation and use
Result description
A liposome drug form is applied intravenously and subsequently irradiated with laser at wavelength in the infrared spectrum which passes deep into tissue. Nanoparticles convert the infrared radiation to wavelength of 670nm which activates phtalocyanines and subsequently disintegration of the tumor tissue.
Keywords
light-upconverting nanoparticlesliposomesphotodynamic therapy of tumorsinfra red light for curing
The result's identifiers
Result code in IS VaVaI
Result on the web
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Liposome drug form with light-converting nanoparticles, a method of its preparation and use
Original language description
A liposome drug form is applied intravenously and subsequently irradiated with laser at wavelength in the infrared spectrum which passes deep into tissue. Nanoparticles convert the infrared radiation to wavelength of 670nm which activates phtalocyanines and subsequently disintegration of the tumor tissue.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
GA19-00676S: Biocompatible surface-engineered upconversion nanoparticles for cancer therapy
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP3697385
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Nov 10, 2021
Owner name
Fyziologický ústav AV ČR, v. v. i.
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
P - Využití výsledku jiným subjektem je v některých případech možné bez nabytí licence
Result type
P - Patent
OECD FORD
Medicinal chemistry
Year of implementation
2021